Statins reduce the risk of atherosclerotic vascular disease in healthy individuals and those with chronic kidney disease (CKD); however, clinical trials have suggested a minimal effect of statins on CKD progression. The PLANET trials compared the renal effects of rosuvastatin and atorvastatin, but the findings leave many questions unanswered.

Original publication

DOI

10.1038/nrneph.2015.36

Type

Journal article

Journal

Nat Rev Nephrol

Publication Date

05/2015

Volume

11

Pages

262 - 263

Keywords

Diabetes Complications, Diabetic Nephropathies, Fluorobenzenes, Heptanoic Acids, Humans, Kidney, Pyrimidines, Pyrroles, Sulfonamides